Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Imaging the neural correlates of cholinergic and behaviour driven rehabilitation in patients with Wernickes aphasia: a double-blinded, cross-over, randomised controlled trial.

Trial Profile

Imaging the neural correlates of cholinergic and behaviour driven rehabilitation in patients with Wernickes aphasia: a double-blinded, cross-over, randomised controlled trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Aphasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jul 2017 Primary endpoint has been met (Correlation between treatment type and improvements on conventional language rating scales acquired in face-to-face interviews with patients. Primary outcome measure, the language modality mean score from the Comprehensive Aphasia Test (CAT). This is a transformed T score with good: test-retest stability, inter-rater reliability and predictive validity.), according to results published in the Journal of Neurology, Neurosurgery and Psychiatry.
    • 14 Jun 2012 Inclusion and exclusion criteria amended as reported by United Kingdom Clinical Research Network record.
    • 01 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top